发明名称 PIPERAZINE DERIVATIVE USEFUL AS CCR5 ANTAGONIST
摘要 PROBLEM TO BE SOLVED: To provide a piperazine derivative useful as a selective CCR5 antagonist. SOLUTION: The invention relates to the use of a CCR5 antagonist expressed by formula (II) or its pharmacologically permissible salt for the treatment of HIV, etc. In the formula, R is phenyl or the like; R<SP>1</SP>is H or an alkyl; R<SP>2</SP>is a phenyl-substituted group, a heteroaryl, naphthyl, fluorenyl, a diphenylmethyl-substituted group or as necessary a phenylalkyl-substituted group; R<SP>3</SP>is H, an alkyl, an alkoxyalkyl, a cycloalkyl, a cycloalkylalkyl or as necessary phenyl or the like; R<SP>4</SP>, R<SP>5</SP>and R<SP>7</SP>are each H or an alkyl; and R<SP>6</SP>is H, an alkyl or an alkenyl. COPYRIGHT: (C)2006,JPO&NCIPI
申请公布号 JP2006052225(A) 申请公布日期 2006.02.23
申请号 JP20050236161 申请日期 2005.08.16
申请人 SCHERING PLOUGH CORP 发明人 BAROUDY BAHIGE M;CLADER JOHN W;JOSIEN HUBERT B;MCCOMBIE STUART W;MCKITTRICK BRIAN A;MILLER MICHAEL W;NEUSTADT BERNARD R;PALANI ANANDAN;SMITH ELIZABETH M;STEENSMA RUO;TAGAT JAYARAM R;VICE SUSAN F;LAUGHLIN MARK A;GILBERT ERIC;LABROLI MARC A
分类号 C07D401/04;A61K31/496;A61K31/497;A61K31/506;A61K31/695;A61K45/00;A61P1/04;A61P11/06;A61P17/00;A61P17/06;A61P19/00;A61P19/02;A61P25/00;A61P25/28;A61P29/00;A61P31/12;A61P31/18;A61P37/00;A61P37/08;A61P43/00;C07D211/58;C07D401/06;C07D401/10;C07D401/14;C07D405/12;C07D405/14;C07D409/06;C07D409/14;C07D413/06;C07D413/14;C07F5/02;C07F7/10;G01F1/46 主分类号 C07D401/04
代理机构 代理人
主权项
地址